Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review
- PMID: 23741608
- PMCID: PMC3363024
- DOI: 10.1098/rsfs.2012.0009
Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review
Abstract
Dendrimers comprise a category of branched materials with diverse functions that can be constructed with defined architectural and chemical structures. When decorated with bioactive ligands made of peptides and saccharides through peripheral chemical groups, dendrimer conjugates are turned into nanomaterials possessing attractive binding properties with the cognate receptors. At the cellular level, bioactive dendrimer conjugates can interact with cells with avidity and selectivity, and this function has particularly stimulated interests in investigating the targeting potential of dendrimer materials for the design of drug delivery systems. In addition, bioactive dendrimer conjugates have so far been studied for their versatile capabilities to enhance stability, solubility and absorption of various types of therapeutics. This review presents a brief discussion on three aspects of the recent studies to use peptide- and saccharide-conjugated dendrimers for drug delivery: (i) synthesis methods, (ii) cell- and tissue-targeting properties and (iii) applications of conjugated dendrimers in drug delivery nanodevices. With more studies to elucidate the structure-function relationship of ligand-dendrimer conjugates in transporting drugs, the conjugated dendrimers hold promise to facilitate targeted delivery and improve drug efficacy for discovery and development of modern pharmaceutics.
Keywords: binding; dendrimer; drug delivery; ligand; targeting.
Figures


Similar articles
-
Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.Adv Drug Deliv Rev. 2005 Dec 14;57(15):2203-14. doi: 10.1016/j.addr.2005.09.014. Epub 2005 Nov 14. Adv Drug Deliv Rev. 2005. PMID: 16290254
-
Preclinical studies of dendrimer prodrugs.Expert Opin Drug Metab Toxicol. 2015;11(8):1303-15. doi: 10.1517/17425255.2015.1052404. Epub 2015 Jun 1. Expert Opin Drug Metab Toxicol. 2015. PMID: 26028253 Review.
-
Dendrimer-based nanocarriers: a versatile platform for drug delivery.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1). doi: 10.1002/wnan.1409. Epub 2016 Apr 29. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017. PMID: 27126551 Review.
-
Poly-glutamic dendrimer-based conjugates for cancer vaccination - a computational design for targeted delivery of antigens.J Drug Target. 2017 Nov-Dec;25(9-10):873-880. doi: 10.1080/1061186X.2017.1363213. Epub 2017 Aug 10. J Drug Target. 2017. PMID: 28795601
-
RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.Colloids Surf B Biointerfaces. 2015 Jan 1;125:82-9. doi: 10.1016/j.colsurfb.2014.11.004. Epub 2014 Nov 11. Colloids Surf B Biointerfaces. 2015. PMID: 25437067
Cited by
-
Potential carriers of chemotherapeutic drugs: matrix based nanoparticulate polymeric systems.Cancer Nanotechnol. 2014;5(1):3. doi: 10.1186/s12645-014-0003-9. Epub 2014 Jun 26. Cancer Nanotechnol. 2014. PMID: 26561511 Free PMC article.
-
Advancements in Nanogels for Enhanced Ocular Drug Delivery: Cutting-Edge Strategies to Overcome Eye Barriers.Gels. 2023 Sep 4;9(9):718. doi: 10.3390/gels9090718. Gels. 2023. PMID: 37754399 Free PMC article. Review.
-
Gold(III) Aryl Complexes as Reagents for Constructing Hybrid Peptide-Based Assemblies via Cysteine S-Arylation.Inorg Chem. 2021 Apr 5;60(7):5054-5062. doi: 10.1021/acs.inorgchem.1c00087. Epub 2021 Mar 19. Inorg Chem. 2021. PMID: 33739101 Free PMC article.
-
Biomimetic Construction of Artificial Selenoenzymes.Biomimetics (Basel). 2023 Jan 28;8(1):54. doi: 10.3390/biomimetics8010054. Biomimetics (Basel). 2023. PMID: 36810385 Free PMC article. Review.
-
Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd.J Biol Chem. 2022 Feb;298(2):101586. doi: 10.1016/j.jbc.2022.101586. Epub 2022 Jan 12. J Biol Chem. 2022. PMID: 35032551 Free PMC article.
References
-
- Tomalia D. A., Baker H., Dewald J., Hall M., Kallos G., Martin S., Roeck J., Ryder J., Smith P. 1985. A new class of polymers: starburst-dendritic macromolecules. Polym. J. 17, 117–132 10.1295/polymj.17.117 (doi:10.1295/polymj.17.117) - DOI - DOI
-
- Frechet J. M. 2002. Dendrimers and supramolecular chemistry. Proc. Natl Acad. Sci. USA 99, 4782–4787 10.1073/pnas.082013899 (doi:10.1073/pnas.082013899) - DOI - DOI - PMC - PubMed
-
- Lee R. T., Lee Y. C. 2000. Affinity enhancement by multivalent lectin–carbohydrate interaction. Glycoconj. J. 17, 543–551 10.1023/A:1011070425430 (doi:10.1023/A:1011070425430) - DOI - DOI - PubMed
-
- Lundquist J. J., Toone E. J. 2002. The cluster glycoside effect. Chem. Rev. 102, 555–578 10.1021/cr000418f (doi:10.1021/cr000418f) - DOI - DOI - PubMed
-
- Boas U., Heegaard P. M. 2004. Dendrimers in drug research. Chem. Soc. Rev. 33, 43–63 10.1039/b309043b (doi:10.1039/b309043b) - DOI - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases